Paul Peter Tak - Chief Executive Officer, Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Paul Peter Tak - trading volume in the past year for Candel Therapeutics, Inc.

Holdings reported by Paul Peter Tak for Candel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 331K $2.14M $6.47 Jul 17, 2024 Direct

Transactions reported by Paul Peter Tak for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.